Product How it works Pricing Blog FAQ About Contact
Español English
EspañolEnglish
Log inCreate free account
Eli Lilly

Eli Lilly (NYSE: LLY) insider transactions

In the twelve months to 10 November 2026, executives and directors of Eli Lilly reported 175 open-market sales of 1,835,959 shares ($77,646m) and 0 open-market purchases, by 5 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in Eli Lilly shares reported on Form 4
DateInsiderRoleTransactionSharesPriceHeld afterFiling
10 November 2026Jonsson PatrikEVP & President, LLY Int'lGift−704—53,443Form 4
3 November 2026Ricks David APresident, Chair, and CEOGift−23,538—555,278Form 4
2 November 2026Hakim AnatEVP, GC & SecretaryOpen-market sale, 10b5-1 plan−5,000$1,402.524,137Form 4
2 November 2026Skovronsky DanielEVP, CS&PO & Pres. LRLGift−119—159,953Form 4
1 November 2026Montarce LucasEVP & CFOOption exercise+1,610—17,868Form 4
1 November 2026Montarce LucasEVP & CFOShares withheld for tax−678$1,417.5417,191Form 4
1 November 2026Hernandez EdgardoEVP & Pres., Mfg. OperationsOption exercise+2,530—48,613Form 4
1 November 2026Hernandez EdgardoEVP & Pres., Mfg. OperationsShares withheld for tax−1,123$1,417.5447,490Form 4
1 November 2026Dozier EricEVP, Chief People OfficerOption exercise+2,300—16,539Form 4
1 November 2026Dozier EricEVP, Chief People OfficerShares withheld for tax−1,019$1,417.5415,520Form 4
1 November 2026Custer Kenneth L.EVP & President, Card Met HlthOption exercise+3,220—13,361Form 4
1 November 2026Custer Kenneth L.EVP & President, Card Met HlthShares withheld for tax−1,425$1,417.5411,935Form 4
1 November 2026Brown Adrienne SEVP, President LLY ImmOption exercise+2,530—10,993Form 4
1 November 2026Brown Adrienne SEVP, President LLY ImmShares withheld for tax−1,099$1,417.549,894Form 4
19 October 2026Fyrwald J ErikDirectorGrant or award+8$1,240.3475,544Form 4
19 October 2026Luciano Juan RDirectorGrant or award+13$1,240.3416,970Form 4
19 October 2026Sulzberger GabrielleDirectorGrant or award+4$1,240.343,016Form 4
19 October 2026Alvarez RalphDirectorGrant or award+10$1,240.3455,848Form 4
21 September 2026Fyrwald J ErikDirectorGrant or award+9$1,164.8975,536Form 4
21 September 2026Luciano Juan RDirectorGrant or award+14$1,164.8916,957Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Eli Lilly page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.